FIELD: chemistry.
SUBSTANCE: invention relates to biotechnology and specifically to a peptide for inhibiting fractalkine-stimulated migration of monocytic cells. The peptide is selected from H-PKEQWVKD-NH2 or H-DAMQHLDRQAAA-NH2.
EFFECT: invention enables synthesis of a peptide without secondary reactions, which inhibits fractalkine-stimulated migration of monocytic cells.
1 dwg, 1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PEPTIDE ELICITING CAPACITY TO INHIBIT MIGRATION OF MONOCYTIC CELLS STIMULATED BY PROTEIN MCP-1 | 2003 |
|
RU2260598C2 |
| PEPTIDE DRUG | 2022 |
|
RU2827765C2 |
| PEPTIDE WITH ABILITY TO INHIBIT MIGRATION OF CELLS STIMULATED BY TARC PROTEIN | 2016 |
|
RU2629198C1 |
| PHARMACEUTICAL COMPOSITION WITH PROLONGED RELEASE OF DODECAPEPTIDE INGRAMON | 2022 |
|
RU2793124C1 |
| ANTIBODIES AGAINST EOTAXIN 2, WHICH RECOGNIZE ADDITIONAL CCR3-BINDING CHEMOKINES | 2015 |
|
RU2705255C2 |
| METHOD OF OBTAINING DODECAPEPTIDE AND TRIPEPTIDE FOR ITS REALISATION | 2007 |
|
RU2340626C1 |
| NONAPEPTIDE AMIDE, POSSESSING ABILITY TO PREVENT INCREASE OF VESSEL ENDOTHELIUM PERMEABILITY | 2009 |
|
RU2402565C1 |
| ANTIBODY AND CHEMOKINE CONSTRUCTS AND USES THEREOF IN IMMUNOLOGICAL DISORDERS | 2001 |
|
RU2252786C2 |
| COMPOSITIONS AND METHODS FOR PRODUCING T-CELLS | 2018 |
|
RU2793344C2 |
| METHOD OF ENHANCEMENT OF IMMUNE RESPONSE TO ANTIGENE IN MAMMALS | 2004 |
|
RU2341289C2 |
